发明名称 ADMINISTRATION OF NEDD8-ACTIVATING ENZYME INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
摘要 Disclosed are methods for the treatment of various solid tumors in patients in need of such treatment. The methods comprise administering to such a patient an NEDD8-activating enzyme (NAE) inhibitor such as (1S,2S,4R)-4-4-(1S)-2,3-dihydro 1H-inden-1-ylamino)-7H-pyrrolo[2,3-d]-pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate (MLN4924) or a pharmaceutically acceptable salt in combination with one or more chemotherapeutic agents. Also disclosed are medicaments for use in the treatment of various solid tumors.
申请公布号 US2016074404(A1) 申请公布日期 2016.03.17
申请号 US201414889571 申请日期 2014.05.13
申请人 MILLENNIUM PHARMACEUTCALS, INC. 发明人 BERGER Allison;LIGHTCAP Eric S.
分类号 A61K31/519;A61K33/24;A61K31/7068;A61K31/555;A61K45/06;A61K31/337 主分类号 A61K31/519
代理机构 代理人
主权项 1. A method of treating a solid tumor, comprising administering to a patient in need of such treatment a combination of ((1S,2S,4R)-4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate or a pharmaceutically acceptable salt thereof, and one or more of: i) a platin ii) a taxane; or iii) gemcitabine.
地址 Cambridge MA US